Patents by Inventor Masanori MURAYAMA

Masanori MURAYAMA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10383917
    Abstract: Provided is an agent for the treatment of an autoimmune disease, the agent comprising C1q/TNF-related protein 3 (CTRP3), and a method for the treatment of an autoimmune disease, the method comprising: administering an agent, which comprises CTRPb3 for the treatment of an autoimmune disease, to a subject in need of a treatment of an autoimmune disease.
    Type: Grant
    Filed: November 14, 2014
    Date of Patent: August 20, 2019
    Assignee: TOKYO UNIVERSITY OF SCIENCE FOUNDATION
    Inventors: Yoichiro Iwakura, Masanori Murayama
  • Publication number: 20160287669
    Abstract: Provided is an agent for the treatment of an autoimmune disease, the agent comprising CTRP3, and a method for the treatment of an autoimmune disease, the method comprising: administering an agent, which comprises CTRP3 for the treatment of an autoimmune disease, to a subject in need of a treatment of an autoimmune disease.
    Type: Application
    Filed: November 14, 2014
    Publication date: October 6, 2016
    Inventors: Yoichiro Iwakura, Masanori Murayama
  • Patent number: 9175054
    Abstract: Provided are methods of suppressing complement alternative pathway in a mammalian subject in need thereof, comprising administering to said subject a therapeutically effective amount of C1q and tumor necrosis factor related protein 6 (CTRP6) or a functional analog thereof.
    Type: Grant
    Filed: May 9, 2012
    Date of Patent: November 3, 2015
    Assignee: The University of Tokyo
    Inventors: Yoichiro Iwakura, Masanori Murayama, Harumichi Ishigame, Shigeru Kakuta
  • Publication number: 20140194343
    Abstract: [Problem] The topic of the present invention is the elucidation of the biological function of CTRP6 and its application. [Solution] A pharmaceutical composition containing CTRP6 for the prevention or treatment of autoimmune disease. Ideally, a pharmaceutical composition for the prevention or treatment of inflammation associated with autoimmune disease, for example, rheumatoid arthritis or type 1 diabetes, is provided.
    Type: Application
    Filed: May 9, 2012
    Publication date: July 10, 2014
    Applicant: THE UNIVERSITY OF TOKYO
    Inventors: Yoichiro Iwakura, Masanori Murayama, Harumichi Ishigame, Shigeru Kakuta
  • Publication number: 20130018270
    Abstract: Provided is an optical observation system that is provided with a portable device, which is secured to an examination subject A and is moved together with the movement of the examination subject, and an external device disposed away from the examination subject, wherein the portable device is provided with a light source; an illumination optical system radiates light coming from the light source onto an observation target site in the examination subject; a detection optical system optically guides light coming from the observation target site; a photodetector detects the light optically guided thereto by the detection optical system and converts the light to an electrical signal; and a transmitter wirelessly transmits the electrical signal output from the photodetector; and the external device is provided with a receiver receives the electrical signal transmitted from the portable device and a signal processor processes the electrical signal received by the receiver.
    Type: Application
    Filed: July 10, 2012
    Publication date: January 17, 2013
    Applicants: RIKEN, OLYMPUS CORPORATION
    Inventors: Masaru MIZUNAKA, Masanori MURAYAMA, Atsushi MIYAWAKI